1-11 of 11
Suzanne L. Topalian
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Five-Year Clinical Outcomes after Neoadjuvant Nivolumab in Resectable Non–Small Cell Lung Cancer

Open Access
Samuel Rosner, Joshua E. Reuss, Marianna Zahurak, Jiajia Zhang, Zhen Zeng, Janis Taube, Valsamo Anagnostou, Kellie N. Smith, Joanne Riemer, Peter B. Illei, Stephen R. Broderick, David R. Jones, Suzanne L. Topalian, Drew M. Pardoll, Julie R. Brahmer, Jamie E. Chaft, Patrick M. Forde
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (4): 705–710.
https://doi.org/10.1158/1078-0432.CCR-22-2994
Published: 16 February 2023
View articletitled, Five-Year Clinical Outcomes after Neoadjuvant Nivolumab in Resectable Non–Small Cell Lung Cancer
Open the PDF for Five-Year Clinical Outcomes after Neoadjuvant Nivolumab in Resectable Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

The Genetic Evolution of Treatment-Resistant Cutaneous, Acral, and Uveal Melanomas

Available to Purchase
Alvin P. Makohon-Moore, Evan J. Lipson, Jody E. Hooper, Amanda Zucker, Jungeui Hong, Craig M. Bielski, Akimasa Hayashi, Collin Tokheim, Priscilla Baez, Rajya Kappagantula, Zachary Kohutek, Vladimir Makarov, Nadeem Riaz, Michael A. Postow, Paul B. Chapman, Rachel Karchin, Nicholas D. Socci, David B. Solit, Timothy A. Chan, Barry S. Taylor, Suzanne L. Topalian, Christine A. Iacobuzio-Donahue
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (5): 1516–1525.
https://doi.org/10.1158/1078-0432.CCR-20-2984
Published: 01 March 2021
View articletitled, The Genetic Evolution of Treatment-Resistant Cutaneous, Acral, and Uveal Melanomas
Open the PDF for The Genetic Evolution of Treatment-Resistant Cutaneous, Acral, and Uveal Melanomas in another window
Includes: Supplementary data
Journal Articles

Neoadjuvant Therapy for Melanoma: A U.S. Food and Drug Administration—Melanoma Research Alliance Public Workshop

Free
Kristen L. Mueller, Marc R. Theoret, Steven J. Lemery, Laleh Amiri-Kordestani, Charlotte E. Ariyan, Michael B. Atkins, Donald A. Berry, Christian U. Blank, Angela M. DeMichele, Patrick M. Forde, Nageatte Ibrahim, Patricia Keegan, Tara C. Mitchell, Rebecca A. Moss, Caroline Robert, Rajeshwari Sridhara, Janis M. Taube, Michael T. Tetzlaff, Jennifer A. Wargo, Keith T. Flaherty, Michael J. Kaplan, Suzanne L. Topalian, Ashley F. Ward, Marc S. Hurlbert
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2021) 27 (2): 394–401.
https://doi.org/10.1158/1078-0432.CCR-20-3285
Published: 19 January 2021
View articletitled, Neoadjuvant Therapy for Melanoma: A U.S. Food and Drug Administration—Melanoma Research Alliance Public Workshop
Open the PDF for Neoadjuvant Therapy for Melanoma: A U.S. Food and Drug Administration—Melanoma Research Alliance Public Workshop in another window
Journal Articles

Pan-Tumor Pathologic Scoring of Response to PD-(L)1 Blockade

Available to Purchase
Julie E. Stein, Evan J. Lipson, Tricia R. Cottrell, Patrick M. Forde, Robert A. Anders, Ashley Cimino-Mathews, Elizabeth D. Thompson, Mohamad E. Allaf, Mark Yarchoan, Josephine Feliciano, Hao Wang, Elizabeth M. Jaffee, Drew M. Pardoll, Suzanne L. Topalian, Janis M. Taube
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (3): 545–551.
https://doi.org/10.1158/1078-0432.CCR-19-2379
Published: 03 February 2020
View articletitled, Pan-Tumor Pathologic Scoring of Response to PD-(L)1 Blockade
Open the PDF for Pan-Tumor Pathologic Scoring of Response to PD-(L)1 Blockade in another window
Includes: Supplementary data
Journal Articles

Transcriptional Mechanisms of Resistance to Anti–PD-1 Therapy

Free
Maria L. Ascierto, Alvin Makohon-Moore, Evan J. Lipson, Janis M. Taube, Tracee L. McMiller, Alan E. Berger, Jinshui Fan, Genevieve J. Kaunitz, Tricia R. Cottrell, Zachary A. Kohutek, Alexander Favorov, Vladimir Makarov, Nadeem Riaz, Timothy A. Chan, Leslie Cope, Ralph H. Hruban, Drew M. Pardoll, Barry S. Taylor, David B. Solit, Christine A. Iacobuzio-Donahue, Suzanne L. Topalian
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2017) 23 (12): 3168–3180.
https://doi.org/10.1158/1078-0432.CCR-17-0270
Published: 14 June 2017
View articletitled, Transcriptional Mechanisms of Resistance to Anti–PD-1 Therapy
Open the PDF for Transcriptional Mechanisms of Resistance to Anti–PD-1 Therapy in another window
Includes: Supplementary data
Journal Articles

Differential Expression of Immune-Regulatory Genes Associated with PD-L1 Display in Melanoma: Implications for PD-1 Pathway Blockade

Free
Janis M. Taube, Geoffrey D. Young, Tracee L. McMiller, Shuming Chen, January T. Salas, Theresa S. Pritchard, Haiying Xu, Alan K. Meeker, Jinshui Fan, Chris Cheadle, Alan E. Berger, Drew M. Pardoll, Suzanne L. Topalian
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2015) 21 (17): 3969–3976.
https://doi.org/10.1158/1078-0432.CCR-15-0244
Published: 31 August 2015
View articletitled, Differential Expression of Immune-Regulatory Genes Associated with PD-L1 Display in Melanoma: Implications for PD-1 Pathway Blockade
Open the PDF for Differential Expression of Immune-Regulatory Genes Associated with PD-L1 Display in Melanoma: Implications for PD-1 Pathway Blockade in another window
Includes: Supplementary data
Journal Articles

Abstract IA01: Immunologic heterogeneity of cancer: Determinants of response and resistance to immunotherapy

Free
Suzanne L. Topalian
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (4_Supplement): IA01.
https://doi.org/10.1158/1557-3265.PMS14-IA01
Published: 13 February 2015
View articletitled, Abstract IA01: Immunologic heterogeneity of cancer: Determinants of response and resistance to immunotherapy
Journal Articles

Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti–PD-1 Therapy

Free
Janis M. Taube, Alison Klein, Julie R. Brahmer, Haiying Xu, Xiaoyu Pan, Jung H. Kim, Lieping Chen, Drew M. Pardoll, Suzanne L. Topalian, Robert A. Anders
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (19): 5064–5074.
https://doi.org/10.1158/1078-0432.CCR-13-3271
Published: 30 September 2014
View articletitled, Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti–PD-1 Therapy
Open the PDF for Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti–PD-1 Therapy in another window
Includes: Supplementary data
Journal Articles

Durable Cancer Regression Off-Treatment and Effective Reinduction Therapy with an Anti-PD-1 Antibody

Free
Evan J. Lipson, William H. Sharfman, Charles G. Drake, Ira Wollner, Janis M. Taube, Robert A. Anders, Haiying Xu, Sheng Yao, Alice Pons, Lieping Chen, Drew M. Pardoll, Julie R. Brahmer, Suzanne L. Topalian
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (2): 462–468.
https://doi.org/10.1158/1078-0432.CCR-12-2625
Published: 16 January 2013
View articletitled, Durable Cancer Regression Off-Treatment and Effective Reinduction Therapy with an Anti-PD-1 Antibody
Open the PDF for Durable Cancer Regression Off-Treatment and Effective Reinduction Therapy with an Anti-PD-1 Antibody in another window
Journal Articles

Evaluation of Prime/Boost Regimens Using Recombinant Poxvirus/Tyrosinase Vaccines for the Treatment of Patients with Metastatic Melanoma

Free
Kimberly R. Lindsey, Linda Gritz, Richard Sherry, Andrea Abati, Patricia A. Fetsch, Lisa C. Goldfeder, Monica I. Gonzales, Kimberly A. Zinnack, Linda Rogers-Freezer, Leah Haworth, Sharon A. Mavroukakis, Donald E. White, Seth M. Steinberg, Nicholas P. Restifo, Dennis L. Panicali, Steven A. Rosenberg, Suzanne L. Topalian
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (8): 2526–2537.
https://doi.org/10.1158/1078-0432.CCR-05-2061
Published: 25 April 2006
View articletitled, Evaluation of Prime/Boost Regimens Using Recombinant Poxvirus/Tyrosinase Vaccines for the Treatment of Patients with Metastatic Melanoma
Open the PDF for Evaluation of Prime/Boost Regimens Using Recombinant Poxvirus/Tyrosinase Vaccines for the Treatment of Patients with Metastatic Melanoma in another window
Journal Articles

Recombinant Fowlpox Viruses Encoding the Anchor-modified gp100 Melanoma Antigen Can Generate Antitumor Immune Responses in Patients with Metastatic Melanoma

Free
Steven A. Rosenberg, James C. Yang, Douglas J. Schwartzentruber, Patrick Hwu, Suzanne L. Topalian, Richard M. Sherry, Nicholas P. Restifo, John R. Wunderlich, Claudia A. Seipp, Linda Rogers-Freezer, Kathleen E. Morton, Sharon A. Mavroukakis, Linda Gritz, Dennis L. Panicali, Donald E. White
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (8): 2973–2980.
Published: 11 August 2003
View articletitled, Recombinant Fowlpox Viruses Encoding the Anchor-modified gp100 Melanoma Antigen Can Generate Antitumor Immune Responses in Patients with Metastatic Melanoma
Open the PDF for Recombinant Fowlpox Viruses Encoding the Anchor-modified gp100 Melanoma Antigen Can Generate Antitumor Immune Responses in Patients with Metastatic Melanoma in another window